Kingdon Capital Management’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-19,250
| Closed | -$1.95M | – | 103 |
|
|
2024
Q1 | $1.95M | Hold |
19,250
| – | – | 0.21% | 67 |
|
|
2023
Q4 | $454K | Hold |
19,250
| – | – | 0.06% | 53 |
|
|
2023
Q3 | $389K | Hold |
19,250
| – | – | 0.04% | 55 |
|
|
2023
Q2 | $501K | Hold |
19,250
| – | – | 0.05% | 55 |
|
|
2023
Q1 | $400K | Hold |
19,250
| – | – | 0.08% | 44 |
|
|
2022
Q4 | $393K | Hold |
19,250
| – | – | 0.08% | 36 |
|
|
2022
Q3 | $531K | Hold |
19,250
| – | – | 0.07% | 42 |
|
|
2022
Q2 | $508K | Hold |
19,250
| – | – | 0.09% | 53 |
|
|
2022
Q1 | $1.54M | Hold |
19,250
| – | – | 0.16% | 59 |
|
|
2021
Q4 | $3.92M | Buy |
19,250
+4,005
| +26% | +$816K | 0.45% | 46 |
|
|
2021
Q3 | $4.93M | Buy |
15,245
+5,074
| +50% | +$1.64M | 0.6% | 36 |
|
|
2021
Q2 | $2.64M | Buy |
+10,171
| New | +$2.64M | 0.31% | 49 |
|